Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Begay-Müller, Valerie Dr. (1) Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Chekulaeva, Marina Dr. (2) Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Franke, Vedran Dr. (1) Gerhardt, Holger Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Haucke, Volker Professor (1) Heuser, Arnd Dr. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (9) Kammertöns, Thomas Dr. (3) Kempa, Stefan Dr. (1) Kieback, Elisa Dr. (1) Kirchner, Marieluise Dr. (2) Kopp, Joachim Dr. (1) Ku, Min-Chi Dr. (1) Kunz, Severine Dr. (1) Landthaler, Markus Prof. Dr. (2) Lewin, Gary Prof. Dr. (1) Mathas, Stephan Dr. (11) Müller, Thomas Dr. (1) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (2) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Poncette, Lucia (1) Poulet, James Prof. Dr. (1) Radke, Michael Dr. (1) Rajewsky, Nikolaus Prof. Dr. (3) Rocks, Oliver Dr. (1) Schlag, Peter M. Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (16) Specker, Edgar Dr. (1) Uckert, Wolfgang Prof. Dr. (4) von Kries, Jens Peter Dr. (1) Willimsky, Gerald Dr. (4) Woehler, Andrew Dr. (1) Zauber, Henrik Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (16) (-) Leisegang, Matthias Prof. Dr. rer. nat. (2) (-) Wolf, Jana Prof. Dr. (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Integrative Vaskuläre Biologie (1) Mathematische Modellierung zellulärer Prozesse (4) Mathematische Zellphysiologie (1) (-) Molekulare Immunologie und Gentherapie (16) (-) Proteom Dynamik (1) Translational Bioinformatics (1) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (2) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (6) 2012 (6) 2013 (12) 2014 (4) 2015 (3) 2016 (4) (-) 2017 (6) 2018 (4) 2019 (6) 2020 (1) 2021 (4) 2022 (6) 2023 (5) 2024 (2) 17 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Wolf, Jana Prof. Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik200820112017 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo 08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 19. Mai 2011 / Nature Global quantification of mammalian gene expression control B. Schwanhaeusser D. Busse N. Li G. Dittmar J. Schuchhardt J. Wolf W. Chen M. Selbach 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo
08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
19. Mai 2011 / Nature Global quantification of mammalian gene expression control B. Schwanhaeusser D. Busse N. Li G. Dittmar J. Schuchhardt J. Wolf W. Chen M. Selbach
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto